Osteolytic lesion
Osteolytic Lesion[edit | edit source]
An osteolytic lesion is a type of bone lesion characterized by the destruction of bone tissue. These lesions are often associated with various bone diseases and conditions, including bone tumors, metastatic cancer, and certain infections. Osteolytic lesions can lead to weakened bone structure and increased risk of fractures.
Pathophysiology[edit | edit source]
Osteolytic lesions occur when there is an imbalance between bone resorption and bone formation. Normally, osteoclasts and osteoblasts work in harmony to maintain bone density and strength. In osteolytic lesions, osteoclast activity is increased, leading to excessive bone resorption. This can be due to the presence of tumor cells that secrete factors stimulating osteoclasts, or due to other pathological processes.
Causes[edit | edit source]
Osteolytic lesions can be caused by a variety of conditions, including:
- Bone tumors: Primary bone tumors such as osteosarcoma and chondrosarcoma can cause osteolytic lesions.
- Metastatic cancer: Cancers such as breast cancer, lung cancer, and prostate cancer can metastasize to bone and cause osteolytic lesions.
- Multiple myeloma: This hematological malignancy is known for causing osteolytic lesions due to the production of osteoclast-activating factors.
- Infections: Certain infections, such as osteomyelitis, can lead to bone destruction and osteolytic lesions.
Diagnosis[edit | edit source]
The diagnosis of osteolytic lesions typically involves imaging studies such as X-rays, CT scans, and MRI. These imaging modalities help in identifying the location, size, and extent of the lesions. Bone biopsy may be performed to determine the underlying cause of the lesion.
Treatment[edit | edit source]
Treatment of osteolytic lesions depends on the underlying cause. Options may include:
- Surgical intervention: To remove the lesion or stabilize the bone.
- Radiation therapy: Particularly in cases of metastatic cancer.
- Chemotherapy: For cancers causing osteolytic lesions.
- Bisphosphonates: Medications that inhibit osteoclast activity and help in reducing bone resorption.
Related Pages[edit | edit source]
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD
